You have 9 free searches left this month | for more free features.

Thrombocythemia, Essential

Showing 1 - 25 of 4,778

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

    Not yet recruiting
    • Myelofibrosis (PMF)
    • +2 more
    • New York, New York
      Ruttenberg Treatment Center
    Apr 18, 2023

    Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

    Not yet recruiting
    • Essential Thrombocythemia
    • Ropeginterferon alfa-2b-njft (P1101)
    • (no location specified)
    Jul 28, 2022

    Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

    Recruiting
    • Essential Thrombocytopenia
    • Recombinant Interferon Alpha
    • Pegylated interferon alfa-2b
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 18, 2022

    Polycythemia Vera, Essential Thrombocythemia, and

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Next-generation sequencing
    • (no location specified)
    Jun 27, 2022

    The Role of Circ0014614 in the Formation and Development of ET

    Recruiting
    • Primary Thrombocytosis
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Jun 18, 2023

      Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

      Active, not recruiting
      • Myeloproliferative Neoplasm
      • +4 more
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Jan 6, 2023

      Thrombocythemia, Essential Trial in San Antonio (IMG-7289)

      Recruiting
      • Thrombocythemia, Essential
      • San Antonio, Texas
        Mays Cancer Center
      Dec 14, 2021

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

      Recruiting
      • Primary Myelofibrosis
      • +4 more
      • New York, New York
        Ruttenberg Treatment Center
      Jul 18, 2022

      Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

      Recruiting
      • Myeloproliferative Neoplasm
      • +3 more
      • CALR allele burden quantification
      • Angers, France
        CHU Angers
      Nov 2, 2022

      Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

      Terminated
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Larkspur, California
      • +2 more
      Nov 14, 2022

      Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

      Not yet recruiting
      • Myelofibrosis
      • +2 more
      • Peptide-based vaccine
      • Poly ICLC
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jun 7, 2022

      Arterial Function and Atherosclerosis in Essential

      Completed
      • Atherosclerosis
      • imaging
      • (no location specified)
      Oct 6, 2021

      Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • +4 more
      • Biospecimen Collection
      • +6 more
      • Los Angeles, California
      • +1 more
      Oct 4, 2023

      Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

      Recruiting
      • Myelofibrosis; Anemia
      • +5 more
      • Jacksonville, Florida
      • +6 more
      Jan 3, 2023

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Worcester, Massachusetts
      • +16 more
      Oct 31, 2022

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Myelofibrosis Trial in Worldwide (PXS-5505)

      Recruiting
      • Myelofibrosis
      • Birmingham, Alabama
      • +19 more
      Nov 28, 2022

      Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

      Completed
      • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 27, 2022

      Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

      Terminated
      • Essential Thrombocythemia
      • +2 more
      • Arsenic Trioxide
      • +3 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 20, 2022